Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Q3 Loss Narrows To SEK 22.5 Mln

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    04/11/2021 07:13
    Nov 4 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * INTERIM REPORT JANUARY-SEPTEMBER 2021
    * Q3 NET REVENUE MSEK 6.2 (2.6)
    * Q3 QUARTERLY LOSS MSEK -22.5 (-24.7)
    * Q3 CASH FLOW FOR PERIOD MSEK-34.5 (-24.6)

Source text for Eikon:  ID:nMFNc7mYYz 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news